CD28 and gastric cancer: We also discovered that the expressions of immune checkpoints, including LGALS9, CD48, CD27, LAG3, CD28, TNFRSF8, CD80, KIR3DL1, CTLA4, and IDO1 were significantly reduced in high NT5DC2 expression metastatic GC samples group.